Will China Products be Banned from U.S. Military Bases?
The House Armed Services Committee passed its version of the National Defense Authorization Act this week, with many amendments taking swipes at China reliance.
New CPA Index Shows U.S. Manufacturers Lost 10% of Domestic Market Share
WASHINGTON — The Coalition for a Prosperous America (CPA) today released its Domestic Market Share Index (DMSI), a new indicator that measures the success of
CPA Statement on Implementation of Uyghur Forced Labor Prevention Act
WASHINGTON — The Coalition for a Prosperous America (CPA) today released a statement in response to the Forced Labor Enforcement Task Force’s (FLETF) release of
Katherine Tai Defends Section 301 China Tariffs in Senate Hearing
In one of her best hearings yet, USTR Katherine Tai holds fast on why the U.S. needs the Section 301 tariffs on China.
China Solar Stocks Rise by 10%-Plus After Not Making Forced Labor List
Homeland Security’s report to Congress on June 17 calls out Xinjiang Daqo New Energy, but leaves out its Shanghai operation listed on the NYSE.
What We Learned from the Latest China Hearing in Washington
The latest Congressional-Executive Commission on China heard from a State and Homeland official on China’s surveillance abroad. What can be done?
CPA Applauds Leader McCarthy and House Republicans’ Letters Supporting Commerce Investigation into Illegal Chinese Circumvention
Republicans Criticize President Biden’s Move to Sabotage Trade Investigation into Chinese Solar Manufacturers WASHINGTON — The Coalition for a Prosperous America (CPA) today applauded House
CPA Applauds Rep. Ryan’s Buy America Solar Bill
WASHINGTON — The Coalition for a Prosperous America (CPA) today applauded legislation introduced by U.S. Representative Tim Ryan (D-OH) that would boost U.S. solar manufacturing
Despite Soaring Profits, Corporations are Asking the Government for China Tariff Cuts, Consumer Benefit Doubtful
Corporate profits grew by double and sometimes triple digits during the COVID-19 pandemic. Worker wages did not.
FDA Advancements Act Passes Committee, Sets Stage for Fall Reauthorization Passage
The FDA Safety and Landmark Advancements (FDASLA) Act has passed a key committee, with 25 out of some 30 amendments passing. Generics and baby formula crisis got most of the attention.
